Sientra Announces FDA-Clearance of Next Generation AlloX2 Pro™ Tissue Expander
Significant Milestone as the First, and Only, MRI-Compatible Tissue Expander Available on the US Market Continues Sientra’s Leadership and Innovation in Breast Reconstruction IRVINE, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“ …